Bank of America
BAC
$53.73
-1.29%
Bank of America Corporation is a diversified financial services giant operating across consumer banking, global wealth and investment management, global banking, and global markets, with a $3.5 trillion balance sheet and the second-largest deposit market share in the United States. The firm is distinct for combining a dominant domestic retail and middle-market franchise with a top-four global investment banking platform and the fourth-largest global trading operation, giving it a balanced mix of fee and spread income. The current investor narrative centers on the tug-of-war between resilient net interest income and rising deposit costs and credit risk, with recent headlines noting that Fed rate hikes offer only modest net interest income benefits while weak investment-banking activity keeps the sector outlook neutral. At the same time, the stock's sharp September pullback and underperformance versus the S&P 500 have refocused debate on whether BAC's premium book value multiple and strong-buy consensus are justified by its earnings trajectory.…
BAC
Bank of America
$53.73
Related headlines
Investment Opinion: Should I buy BAC Today?
BAC earns a Buy rating based on its strong buy consensus (mean 1.5) and average target price of $68.62, implying 21.0% upside from $56.70. The core thesis is that BAC is undervalued relative to its earnings growth, with a forward PE of 10.72x and a PEG of 0.73, while its profitability and capital return are improving. Supporting evidence includes a 5.84% YoY revenue growth in Q2 2026, net margin expansion to 18.37% from 15.25%, and a 2.36% dividend yield backed by $56.57B in trailing free cash flow. The forward PE of 10.72x is well below the trailing 14.18x, and the PEG below 1.0 suggests the market is not fully pricing in expected EPS of $6.82. However, risks include a premium price-to-book of 1.34x, which is near the top of its historical range, and potential credit deterioration if the economy slows. The rating would upgrade to Strong Buy if the stock pulls back to $50 (forward PE ~7.3x) or if NII accelerates; it would downgrade to Hold if revenue growth falls below 3% or if credit costs spike. Relative to its history and peers, BAC appears fairly valued to slightly undervalued, with the forward PE and PEG offering a margin of safety.
Sign up to view all
BAC 12-Month Price Forecast
BAC presents a compelling risk/reward proposition, with a forward PE of 10.72x and a PEG of 0.73 indicating the stock is cheap relative to expected growth. The strong buy consensus and 21% upside to the average target reflect confidence in the franchise, while margin expansion and robust capital return support the bull case. However, the premium price-to-book of 1.34x and recent relative underperformance warrant caution. I would upgrade to high confidence if BAC breaks above $65.23 (52-week high) or if NII growth accelerates; I would downgrade to neutral if credit costs rise or if the stock breaks below $50.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Bank of America's 12-month outlook, with a consensus price target around $68.62 and implied upside of +27.7% versus the current price.
Average Target
$68.62
0 analysts
Implied Upside
+27.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$62 - $76
Analyst target range
Coverage is robust with 21 analysts, and the consensus recommendation is a strong buy with a recommendation mean of 1.5 on a scale where 1.0 is a strong buy and 5.0 is a sell. The average target price of $68.62 implies roughly 21.0% upside from the current price of $56.70, a substantial gap that suggests the sell-side views the recent September pullback as an opportunity rather than a warning. The consensus leans decisively bullish, with the strong-buy rating supported by a cluster of Overweight, Outperform, and Buy ratings from major firms including Wells Fargo, Barclays, RBC Capital, UBS, JP Morgan, and Truist Securities, and no downgrades appearing in the recent institutional ratings data. The target range spans $62.00 to $76.00, a spread of $14.00, or about 22.6% of the average target, which signals meaningful dispersion in analyst views and therefore elevated uncertainty about the earnings trajectory. The high target of $76.00 implies roughly 34.0% upside and would require multiple expansion toward 15x forward earnings plus successful execution on net interest income and capital return, while the low target of $62.00 implies about 9.4% upside and prices in a more conservative scenario of margin compression or slower loan growth. Notably, the low target of $62.00 sits above the current price of $56.70, meaning even the most cautious analyst sees upside — a rare configuration that typically reflects confidence in the franchise but also raises the risk of crowded positioning if the macro backdrop deteriorates. The recent institutional ratings are uniformly reiterations rather than upgrades, with the most recent actions dated July 15, 2026, suggesting analysts have not yet updated their views following the September selloff; if the pullback persists, downgrades or target cuts could become a near-term risk. The estimated EPS range of $6.68 to $7.00 for the year is tight, indicating high confidence in near-term earnings, which contrasts with the wider price-target spread and suggests the uncertainty is more about the multiple the market will pay than about the earnings themselves.
Bulls vs Bears: BAC Investment Factors
The bull case rests on BAC's strong buy consensus, 21% upside to the average target, and a forward PE of 10.72x with a PEG of 0.73, which suggest the stock is undervalued relative to growth. Margin expansion and robust capital return further support the positive narrative. However, the bear case highlights persistent relative underperformance, a premium price-to-book multiple, and revenue lumpiness that could cap upside. The most critical tension is whether BAC can sustain its margin improvement and deliver on earnings growth to justify its book value premium; if credit costs rise or NII disappoints, the stock could re-rate lower. Currently, the bull evidence—valuation, analyst sentiment, and profitability trends—outweighs the bear concerns, but the recent momentum breakdown warrants caution.
Bullish
- Strong Buy Consensus with 21% Upside: 21 analysts rate BAC a strong buy (mean 1.5), with an average target price of $68.62 implying 21.0% upside from $56.70. Even the lowest target of $62.00 sits 9.4% above the current price, a rare configuration indicating broad-based confidence in the franchise.
- Attractive Forward Valuation and PEG: BAC trades at a forward PE of 10.72x, a 24% discount to its trailing PE of 14.18x, and a PEG ratio of 0.73, well below 1.0. This suggests the market is underpricing expected earnings growth, especially with consensus EPS of $6.82 for the year.
- Margin Expansion and Profitability Gains: Net margin expanded to 18.37% in Q2 2026 from 15.25% a year earlier, while operating margin rose to 23.41% from 16.47%. Lower interest expense ($17.84B vs. $20.20B) and disciplined cost control ($37.83B vs. $38.98B) drove the improvement.
- Solid Capital Return and Dividend: BAC pays a 2.36% dividend yield with a conservative 31.3% payout ratio, supported by $56.57B in trailing free cash flow. The company repurchased $7.24B of stock in Q1 2026, enhancing per-share value.
Bearish
- Relative Underperformance and Weak Momentum: BAC has lagged SPY by 9.58 percentage points over the past month and 7.87 points over the past year, with a 1-month decline of 8.89%. The stock sits at $56.70, only 55.5% up its 52-week range, signaling fading momentum.
- Premium Price-to-Book Leaves Little Room: At 1.34x price-to-book, BAC trades near the top of its 3-year range (0.76x–1.36x). This premium prices in optimistic ROE expectations, but any credit deterioration or NII disappointment could trigger multiple compression.
- Lumpy Revenue and Earnings Volatility: Revenue growth is uneven: Q2 2026 revenue of $49.39B rose 5.84% YoY, but Q1 2026 revenue was only $30.27B due to reporting composition differences. Quarterly FCF swung from $41.77B in Q1 2026 to -$22.95B in Q4 2025, highlighting earnings unpredictability.
- Rising Deposit Costs and Credit Risks: Recent news notes that Fed rate hikes offer only modest NII benefits as rising deposit costs and credit risks limit upside. BAC's net interest income could face pressure if funding costs continue to climb while loan growth remains tepid.
BAC Technical Analysis
BAC is in a broad recovery uptrend that has stalled, with the shares up 9.35% over the past year but sitting at $56.70, only about 55.5% of the way up its 52-week range of $46.12 to $65.23. That mid-range positioning signals neither momentum-driven overextension nor deep-value distress, but rather a stock that has given back a meaningful portion of its earlier advance after peaking near $65.23. With a 6-month gain of 20.72% against a 1-year gain of just 9.35%, the bulk of the trailing-year return was generated in the first half of the period, and the recent fade suggests the market is reassessing the durability of that move. Short-term momentum has deteriorated sharply: the stock is down 8.89% over the past month and 2.04% over three months, a clear deceleration from the 6-month trend and a divergence that often signals either a healthy mean-reversion pause or the early stage of a trend reversal. Relative strength confirms the weakness, with BAC lagging SPY by 9.58 percentage points over one month and 7.87 points over one year, while the S&P 500 gained 17.22% versus BAC's 9.35% — a persistent performance gap that argues against chasing the name until momentum stabilizes. The most recent session did show a modest bounce, with the stock up 1.20% to $56.70 from a prior close of $56.03 on volume of roughly 28.6 million shares, but that single-day rebound does little to offset the month-long slide. Key technical levels are well defined: support sits at the 52-week low of $46.12, roughly 18.7% below the current price, while resistance is the 52-week high of $65.23, about 15.0% above. A decisive break above $65.23 would confirm a resumption of the primary uptrend and likely draw momentum buyers, whereas a breakdown below $46.12 would signal a full trend reversal and validate the recent relative-strength deterioration. With a beta of 1.164, BAC is roughly 16% more volatile than the market, meaning position sizing should account for amplified moves in both directions; the 18.39% maximum drawdown over the period underscores that this is not a low-volatility holding.
Beta
1.16
1.16x market volatility
Max Drawdown
-18.4%
Largest decline past year
52-Week Range
$46-$65
Price range past year
Annual Return
+6.0%
Cumulative gain past year
| Period | BAC Return | S&P 500 |
|---|---|---|
| 1m | -13.3% | +0.3% |
| 3m | -8.5% | +2.6% |
| 6m | +8.8% | +16.5% |
| 1y | +6.0% | +14.3% |
| ytd | -4.0% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BAC Fundamental Analysis
BAC's revenue trajectory is growing but lumpy, with Q2 2026 revenue of $49.39 billion up 5.84% year over year from $46.67 billion in Q2 2025, and net income of $9.07 billion translating to diluted EPS of $1.20. The multi-quarter trend shows sequential improvement from Q1 2026 revenue of $30.27 billion and net income of $8.58 billion, though the Q1 figure reflects a different reporting composition with a 95.6% gross margin versus Q2's 61.1%, making clean sequential comparisons difficult. Segment data for the latest period shows Consumer Banking at $11.05 billion, Global Markets at $7.11 billion, Global Wealth and Investment Management at $6.71 billion, and Global Banking at $6.29 billion, indicating that the consumer franchise and trading operations are the largest revenue contributors while global banking remains the smallest. The 5.84% YoY growth is respectable for a money-center bank but not accelerating, and with estimated full-year revenue of $133.4 billion against a $405 billion market cap, the investment case rests more on margin and capital return than on top-line expansion. Profitability is solid and improving: Q2 2026 net income of $9.07 billion produced a net margin of 18.37%, up from 15.25% in Q2 2025 and 14.19% in Q4 2024, while gross margin expanded to 61.13% from 53.30% a year earlier. Operating margin of 23.41% in Q2 2026 compares favorably to 16.47% in Q2 2025 and 15.13% in Q4 2024, and the company-level operating margin of 19.68% with a net margin of 15.93% confirms a genuine multi-quarter margin expansion story. The improvement is driven by lower interest expense — $17.84 billion in Q2 2026 versus $20.20 billion in Q2 2025 — and disciplined cost control, with cost and expenses of $37.83 billion against $38.98 billion a year prior, though the 21.5% effective tax rate in Q2 2026 was higher than the unusually low 7.4% rate in Q2 2025. Balance sheet and cash flow metrics are healthy for a bank: ROE of 10.06% and ROA of 0.97% are respectable, debt-to-equity of 1.21 is moderate, and trailing free cash flow of $56.57 billion comfortably covers the 31.3% payout ratio and 2.36% dividend yield. However, the current ratio of 0.42 and quarterly FCF volatility — from $41.77 billion in Q1 2026 to negative $22.95 billion in Q4 2025 — reflect the inherently lumpy working-capital dynamics of a trading and lending operation rather than a liquidity concern, and the $242.5 billion cash balance at the end of Q1 2026 provides ample funding capacity. The company is generating more than enough internal cash to fund growth, buy back stock ($7.24 billion repurchased in Q1 2026), and pay dividends, which supports the case that financial risk is contained despite the leveraged balance sheet.
Quarterly Revenue
$49.4B
2026-06
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
61.1%
Latest Quarter
Free Cash Flow
$94.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BAC Overvalued?
Because BAC is solidly profitable with trailing net income positive, the PE ratio is the appropriate primary metric, and the stock trades at a trailing PE of 14.18x against a forward PE of 10.72x — a roughly 24% compression that implies the market expects meaningful earnings growth, consistent with the consensus EPS estimate of $6.82 versus the current run-rate. The PEG ratio of 0.73, well below 1.0, suggests the stock is inexpensive relative to its expected growth rate, and the 2.36% dividend yield with a conservative 31.3% payout ratio adds an income dimension that supports the valuation. On a price-to-book basis, BAC trades at 1.34x, which for a money-center bank is a modest premium to book but not stretched, while the price-to-sales ratio of 2.11x and EV/EBITDA of 13.48x round out a valuation profile that looks reasonable rather than rich. Relative to the broader diversified banking sector, BAC's 14.18x trailing PE and 1.34x price-to-book sit near the middle of the peer range — neither the deep discount of a troubled institution nor the premium of a best-in-class compounder — and the 10.72x forward PE implies the market is pricing in roughly 24% earnings growth, which is achievable if net interest income stabilizes and credit costs remain contained. The 0.73 PEG ratio is the most compelling data point, suggesting that if BAC delivers on consensus estimates, investors are paying less than one times growth, a discount that would typically be justified only by concerns about credit quality, regulatory capital requirements, or slower-than-expected rate benefits. Historically, BAC's PE has ranged from roughly 7.5x in mid-2023 to 23.4x in late 2023, with the current 14.18x sitting in the middle of that band and well below the 2021 peak of 13.56x on a price-to-sales basis of 15.77x. The price-to-book multiple of 1.34x is above the 0.76x–1.36x range seen over the past three years, placing it near the top of its own historical band, which suggests the market is pricing in optimistic expectations for returns on equity and capital return. The combination of a mid-range PE, a top-of-range price-to-book, and a sub-1.0 PEG creates a mixed picture: the earnings multiple looks fair, but the book value premium leaves little room for disappointment if credit costs rise or net interest income disappoints.
PE
14.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 8x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks for BAC center on its leveraged balance sheet and earnings volatility. With a debt-to-equity ratio of 1.21 and a current ratio of 0.42, the bank operates with significant financial leverage, typical for the sector but amplifying sensitivity to credit cycles. Quarterly free cash flow is highly volatile, swinging from $41.77B in Q1 2026 to -$22.95B in Q4 2025, reflecting lumpy trading and lending activities. Additionally, revenue concentration in Consumer Banking ($11.05B) and Global Markets ($7.11B) exposes BAC to consumer credit deterioration and market volatility, while the 5.84% YoY revenue growth is modest and not accelerating. Market and competitive risks include valuation compression if BAC's premium price-to-book (1.34x) reverts toward its historical mid-range. The stock's beta of 1.164 means it is 16% more volatile than the market, and its 1-month relative strength of -9.58% versus SPY highlights underperformance. Regulatory headwinds, such as potential capital requirement increases, and competitive pressures from fintech and other money-center banks could erode market share. Recent news indicates that Fed rate hikes offer only modest NII benefits due to rising deposit costs, keeping the sector outlook neutral. The worst-case scenario involves a severe recession triggering credit losses, a flattening yield curve compressing NII, and a regulatory crackdown on capital returns. In such a scenario, BAC could retest its 52-week low of $46.12, representing an 18.7% decline from the current price of $56.70. If analyst bear-case targets are met, the downside could be limited to $62.00, but a broader market selloff could push shares below $50, implying a 12% loss. The maximum drawdown over the past period was 18.39%, underscoring the potential for significant capital erosion in adverse conditions.
FAQ
The key risks include: 1) Credit risk – a recession could trigger loan losses, especially in consumer banking ($11.05B revenue); 2) Interest rate risk – rising deposit costs could compress net interest income, as noted in recent news; 3) Valuation risk – the 1.34x price-to-book premium could contract if ROE declines; 4) Regulatory risk – potential capital requirement increases could reduce capital return. The most severe is credit risk, which could push the stock toward its 52-week low of $46.12, an 18.7% decline.
The 12-month forecast is bullish, with a base case (50% probability) targeting $62–$68.62, a bull case (30%) targeting $68.62–$76, and a bear case (20%) targeting $46.12–$62. The base case assumes stable rates and EPS of $6.82, while the bull case requires NII growth and multiple expansion. The most likely scenario is the base case, driven by steady capital return and margin stability. Key catalysts include Fed policy, investment banking recovery, and credit quality trends.
BAC appears fairly valued to slightly undervalued. Its trailing PE of 14.18x is mid-range historically, but the forward PE of 10.72x and PEG of 0.73 indicate the market is not fully pricing in expected earnings growth. The price-to-book of 1.34x is near the top of its 3-year range (0.76x–1.36x), suggesting a premium that could limit upside if returns disappoint. Compared to peers, BAC's valuation is average, but the forward earnings multiple offers a margin of safety if consensus EPS of $6.82 is achieved.
BAC appears to be a good buy for value-oriented investors, with a forward PE of 10.72x and a PEG of 0.73 suggesting undervaluation relative to growth. The strong buy consensus and average target of $68.62 imply 21% upside, while the 2.36% dividend yield and $56.57B free cash flow support income and stability. However, the premium price-to-book of 1.34x and recent 8.89% one-month decline highlight risks. It is most suitable for investors with a medium to long-term horizon who can tolerate sector volatility (beta 1.164).
BAC is more suitable for long-term investment (minimum 2-3 years) given its cyclical nature, 2.36% dividend yield, and beta of 1.164. Short-term trading is risky due to earnings volatility and macro sensitivity, as shown by the 18.39% max drawdown. Long-term investors can benefit from compounding dividends and share buybacks, while the forward PE of 10.72x offers a reasonable entry point. A holding period of at least 2 years allows time for net interest income recovery and credit cycle normalization.